• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

CRISPR Cas9 protein delivery via virus-like particles for in vivo treatment of Duchenne muscular dystrophy

Research Project

Project/Area Number 17K15048
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field System genome science
Research InstitutionKyoto University

Principal Investigator

Gee Peter David  京都大学, iPS細胞研究所, 特定研究員 (00754227)

Project Period (FY) 2017-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2018: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2017: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
KeywordsCRISPR / DMD / Genome editing / Delivery / Virus-like particles / CRISPR Cas9 / ゲノム / 遺伝子 / ウィルス / 再生医療 / 細胞
Outline of Final Research Achievements

We developed a novel protein delivery system based on virus-like particles that we term NanoMEDIC (nanomembrane-derived extracellular vesicles for the delivery of macromolecular cargo) which can be used to deliver proteins of interest in a variety of cell types including human iPS cells, monocytes, T cells, cancer cell lines, and also in vivo. In particular, genome editing technology such as CRISPR-Cas9 could be delivered into a variety of cells and achieved high editing efficiency. The system utilizes the FKBP12 and FRB dimerization domains fused with HIV-Gag and SpCas9, respectively. We optimized the FRB-SpCas9 fusion protein by testing the incorporation of SpCas9 when FRB was fused either to the N-, C- or N- and C- terminal ends of the protein. Furthermore, mutation of the FRB domain abrogated the dimerization activity.

Academic Significance and Societal Importance of the Research Achievements

Transient delivery of CRISPR-Cas9 RNP will allow for safer use of genome editing technology in vivo and may be applicable future clinical work. We also developed a serum-free culture system using flow electroporation to potentially apply the production of our NanoMEDIC system for industrial use.

Report

(3 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • Research Products

    (4 results)

All 2018

All Journal Article (1 results) (of which Peer Reviewed: 1 results,  Open Access: 1 results) Presentation (2 results) (of which Int'l Joint Research: 2 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Site-specific randomization of the endogenous genome by a regulatable CRISPR-Cas9 piggyBac system in human cells2018

    • Author(s)
      Kentaro Ishida, Huaigeng Xu, Noriko Sasakawa, Mandy Siu Yu Lung, Julia Alexandra Kudryashev, Peter Gee & Akitsu Hotta
    • Journal Title

      Scientific Reports

      Volume: online Issue: 1 Pages: 310-310

    • DOI

      10.1038/s41598-017-18568-4

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] Development of a CRISPR-Cas9 RNP delivery system using virus-like particles2018

    • Author(s)
      Peter Gee
    • Organizer
      The 3rd Annual Meeting of The Japanese Society for Genome Editing in Hiroshima
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] CRISPR Cas9 delivery via virus-like particles for in vivo genome editing2018

    • Author(s)
      Peter Gee
    • Organizer
      9th Takeda Science Symposium on PharmaSciences (Genome Editing Towards Medicinal Applications)
    • Related Report
      2017 Research-status Report
    • Int'l Joint Research
  • [Patent(Industrial Property Rights)] ウイルス様粒子及びその使用2018

    • Inventor(s)
      Peter Gee and Akitsu Hotta
    • Industrial Property Rights Holder
      Peter Gee and Akitsu Hotta
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2018-133682
    • Filing Date
      2018
    • Related Report
      2018 Annual Research Report

URL: 

Published: 2017-04-28   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi